山东大学耳鼻喉眼学报 ›› 2024, Vol. 38 ›› Issue (6): 23-29.doi: 10.6040/j.issn.1673-3770.0.2023.489

• 研究进展 • 上一篇    下一篇

咽喉反流性疾病在常见呼吸道疾病中的作用

张利,张梦茹,阿丽米热·艾尔肯,邱忠民   

  1. 同济大学附属同济医院 呼吸与危重症医学科, 上海 200065
  • 发布日期:2024-12-13
  • 通讯作者: 邱忠民. E-mail:qiuzhongmin@tongji.edu.cn
  • 基金资助:
    上海市科委课题(20Y11902500,21140903400)

Role of pharyngeal reflux in common respiratory diseases

ZHANG Li, ZHANG Mengru, Alimire Aierken, QIU Zhongmin   

  1. Department of Pulmonary and Critical Care Medicine, Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China
  • Published:2024-12-13

摘要: 咽喉反流(laryngopharyngeal reflux, LPR)是胃食管反流病的一种食管外表现形式,涉及多学科疾病,临床表现多变且缺乏特异性,其确切的发病机制尚不明确。消化道(胃、食管等)与呼吸道毗邻,有共同的前肠胚胎起源和迷走神经支配,两者通过食管-气管支气管反射或气管支气管-食管反射密切联系,相互影响。LPR是上、下呼吸道气道炎症的潜在促发因素,与多种呼吸道疾病(如慢性咳嗽、慢性鼻-鼻窦炎、哮喘、慢性阻塞性肺病、阻塞性睡眠呼吸暂停低通气综合征、特发性肺纤维化等)相关。在临床实践中治疗伴有LPR的呼吸系统疾病患者时应考虑多种疗法联合治疗,为患者提供个体化治疗方案。论文就LPR在常见呼吸道疾病中的作用进行综述。

关键词: 咽喉反流, 胃食管反流, 迷走神经, 呼吸道, 抗反流

Abstract: Laryngopharyngeal reflux(LPR)is an extraesophageal manifestation of gastroesophageal reflux disease(GERD), involving multiple disciplines, with variable and nonspecific clinical presentations, and its exact pathogenesis remains unclear. The gastrointestinal tract(stomach, oesophagus, etc.)is adjacent to the respiratory tract, sharing a common foregut embryonic origin and vagal innervation. The two are closely linked by the oesophago-tracheobronchial or tracheobronchial-esophageal reflex and influence each other. LPR is a potential precipitating factor for upper and lower airway inflammation and is associated with several respiratory diseases(e.g. chronic cough, chronic rhinosinusitis, asthma, obstructive sleep apnoea-hypopnoea syndrome, chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis). In clinical practice, the management of patients with respiratory diseases associated with LPR should consider a combination of therapeutic approaches to provide individualized treatment plans for patients. This article provides an overview of the role of LPR in common respiratory diseases.

Key words: Laryngopharyngeal reflux, Gastroesophageal reflux, Vagal nerve, Respiratory tract, Anti-reflux

中图分类号: 

  • R766.5
[1] Na C, Ting D, Yang L, et al. Laryngopharyngeal reflux disease: Updated examination of mechanisms, pathophysiology, treatment, and association with gastroesophageal reflux disease[J]. World J Gastroenterol, 2024, 30(16):2209-2219. doi: 10.3748/wjg.v30.i16.2209
[2] Lechien JR. Clinical update findings about pH-impedance monitoring features in laryngopharyngeal reflux patients[J]. J Clin Med, 2022, 11(11): 3158. doi:10.3390/jcm11113158
[3] Lechien JR, Mouawad F, Bobin F, et al. Review of management of laryngopharyngeal reflux disease[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2021,138(4): 257-267. doi:10.1016/j.anorl.2020.11.002
[4] Zhang L, Aierken A, Zhang M, et al. Pathogenesis and management of gastroesophageal reflux disease-associated cough: a narrative review [J]. J Thorac Dis, 2023, 15(4): 2314-2323. doi: 10.21037/jtd-22-1757
[5] Chung KF, McGarvey L, Song WJ, et al. Cough hypersensitivity and chronic cough[J]. Nat Rev Dis Primers, 2022, 8(1): 45. doi:10.1038/s41572-022-00370-w
[6] Zhao Y, Han HL, Lu QP, et al. Characteristics of laryngopharyngeal reflux in patients with chronic cough induced by gastroesophageal reflux disease[J]. Ear Nose Throat J, 2023: 1455613231205393. doi:10.1177/01455613231205393
[7] Chen Q, Dong R, Zhang L, et al. Tracheobronchial-esophageal reflex initiates esophageal hypersensitivity and aggravates cough hyperreactivity in guinea pigs with esophageal acid infusion[J]. Respir Physiol Neurobiol, 2022, 301: 103890. doi:10.1016/j.resp.2022.103890
[8] Zhang L, Zhang MR, Aierken A, et al. Role of alveolar nitric oxide in gastroesophageal reflux-associated cough: prospective observational study[J]. Ther Adv Respir Dis, 2024, 18: 17534666241231117. doi:10.1177/17534666241231117
[9] 陈强,张利,邱忠民. 胃食管反流性咳嗽的诊治:共识与争议[J].中华结核和呼吸杂志, 2022, 45(1):6-9. doi:10.3760/cma.j.cn112147-20210922-00660 CHEN Qiang, ZHANG Li, QIU Zhongmin. Diagnosis and treatment of gastroesophageal reflux-related cough: consensus and controversies[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2022, 45(1):6-9. doi:10.3760/cma.j.cn112147-20210922-00660
[10] Zhang MR, Morice AH, Si FL, et al. Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study[J]. Ther Adv Respir Dis, 2023, 17: 17534666231167716. doi:10.1177/17534666231167716
[11] Zhu YQ, Xu XH, Zhang MR, et al. Pressure and length of the lower esophageal sphincter as predictive indicators of therapeutic efficacy of baclofen for refractory gastroesophageal reflux-induced chronic cough[J]. Respir Med, 2021, 183: 106439. doi:10.1016/j.rmed.2021.106439
[12] Zhang MR, Chen Q, Dong R, et al. Prediction of therapeutic efficacy of gabapentin by Hull Airway Reflux Questionnaire in chronic refractory cough[J]. Ther Adv Chronic Dis, 2020, 11: 2040622320982463. doi:10.1177/2040622320982463
[13] Zhang MR, Morice AH, Si FL, et al. New insights into refractory chronic cough and unexplained chronic cough: a 6-year ambispective cohort study[J]. Allergy Asthma Immunol Res, 2023, 15(6): 795-811. doi:10.4168/aair.2023.15.6.795
[14] Aldajani A, Alhussain F, Mesallam T, et al. Association between chronic rhinosinusitis and reflux diseases in adults: a systematic review and meta-analysis[J]. Am J Rhinol Allergy, 2024, 38(1): 47-59. doi:10.1177/19458924231210028
[15] Chen G, Guo WC, Liu SR, et al. Causal analysis between gastroesophageal reflux disease and chronic rhinosinusitis[J]. Eur Arch Otorhinolaryngol, 2024, 281(4): 1819-1825. doi:10.1007/s00405-023-08350-w
[16] Lechien JR, Saussez S, Hopkins C. Association between laryngopharyngeal reflux, gastroesophageal reflux and recalcitrant chronic rhinosinusitis: a systematic review[J]. Clin Otolaryngol, 2023, 48(4): 501-514. doi:10.1111/coa.14047
[17] Bergqvist J, Bove M, Andersson A, et al. Dose-dependent relationship between nocturnal gastroesophageal reflux and chronic rhinosinusitis in a middle-aged population: results from the SCAPIS pilot[J]. Rhinology, 2023, 61(2): 118-123. doi:10.4193/Rhin22.297
[18] 曾宪廷,王广科,孙占伟,等.伴咽喉反流的难治性鼻窦炎术后应用质子泵抑制剂的疗效观察[J].山东大学耳鼻喉眼学报,2022, 36(3): 189-194. doi:10.6040/j.issn.1673-3770.0.2021.512 ZENG Xianting, WANG Guangke, SUN Zhanwei, et al. Postoperative efficacy of proton pump inhibitor in the treatment of difficult-to-treat rhinosinusitis with laryngopharyngeal reflux[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 189-194. doi:10.6040/j.issn.1673-3770.0.2021.512
[19] Grandes XA, Talanki Manjunatha R, Habib S, et al. Gastroesophageal reflux disease and asthma: a narrative review[J]. Cureus, 2022, 14(5): e24917. doi:10.7759/cureus.24917
[20] He J, Wang CM, Li WC. Laryngopharyngeal reflux in obstructive sleep apnea-hypopnea syndrome: an updated meta-analysis[J]. Nat Sci Sleep, 2022, 14: 2189-2201. doi:10.2147/NSS.S390272
[21] Chen G, Xi F, Zhu RK, et al. Distribution of LPRD in OSAHS patients: is there a correlation?[J]. Altern Ther Health Med, 2024, 30(11):40-43
[22] Bobin F, Lechien JR. Association between oropharyngeal ph-monitoring, pepsin saliva concentration and degree of apnea-hypopnea index of obstructive sleep apnea[J]. Le J D'oto Rhino Laryngol De Chir Cervico Faciale, 2023, 52(1): 68. doi:10.1186/s40463-023-00675-0
[23] Campanholo MAT, Caparroz FA, Vidigal TA, et al. Assessment of laryngopharyngeal reflux and obstructive sleep apnea: a population-based study[J]. Laryngoscope, 2022, 132(9): 1877-1882. doi:10.1002/lary.30061
[24] 王宏艳,王三春,滕博,等.阻塞性睡眠呼吸暂停综合征与咽喉反流性疾病相关研究进展[J].山东大学耳鼻喉眼学报,2020, 34(4): 134-138. doi:10.6040/j.issn.1673-3770.0.2019.565 WANG Hongyan, WANG Sanchun, TENG Bo, et al. Advances in the study of obstructive sleep apnea syndrome and laryngopharyngeal reflux disease[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(4): 134-138. doi:10.6040/j.issn.1673-3770.0.2019.565
[25] Wang L, Han HL, Wang G, et al. Relationship between reflux diseases and obstructive sleep apnea together with continuous positive airway pressure treatment efficiency analysis[J]. Sleep Med, 2020, 75: 151-155. doi:10.1016/j.sleep.2020.07.024
[26] Yoon YH, Park KW, Lee SH, et al. Efficacy of three proton-pump inhibitor therapeutic strategies on laryngopharyngeal reflux disease; a prospective randomized double-blind study[J]. Clin Otolaryngol, 2019, 44(4): 612-618. doi:10.1111/coa.13345
[27] Sanchez J, Schumann DM, Karakioulaki M, et al. Laryngopharyngeal reflux in chronic obstructive pulmonary disease- a multi-centre study[J]. Respir Res, 2020, 21(1): 220. doi:10.1186/s12931-020-01473-2
[28] Eryuksel E, Dogan M, Olgun S, et al. Incidence and treatment results of laryngopharyngeal reflux in chronic obstructive pulmonary disease[J]. Eur Arch Otorhinolaryngol, 2009, 266(8): 1267-1271. doi:10.1007/s00405-009-0922-y
[29] Pandolfino JE, Kahrilas PJ. Smoking and gastro-oesophageal reflux disease[J]. Eur J Gastroenterol Hepatol, 2000, 12(8): 837-842. doi:10.1097/00042737-200012080-00002
[30] Gadel AA, Mostafa M, Younis A, et al. Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease[J]. Hepatogastroenterology, 2012, 59(120): 2498-2502. doi:10.5754/hge10433
[31] Lazenby JP, Guzzo MR, Harding SM, et al. Oral corticosteroids increase esophageal acid contact times in patients with stable asthma[J]. Chest, 2002, 121(2): 625-634. doi:10.1378/chest.121.2.625
[32] Hamdan AL, Ziade G, Turfe Z, et al. Laryngopharyngeal symptoms in patients with chronic obstructive pulmonary disease[J]. Eur Arch Otorhinolaryngol, 2016, 273(4): 953-958. doi:10.1007/s00405-015-3830-3
[33] Wang HY, Fu ZM, Xu PH, et al. Proton pump inhibitor treatment improves pulmonary function in acute exacerbations of COPD patients with 24-hour Dx-pH monitoring-diagnosed laryngopharyngeal reflux[J]. Clin Respir J, 2021, 15(5): 558-567. doi:10.1111/crj.13347
[34] Kang J, Lee R, Lee SW. Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD[J]. Respir Res, 2023, 24(1): 75. doi:10.1186/s12931-023-02345-1
[35] Ruaro B, Pozzan R, Confalonieri P, et al. Gastroesophageal reflux disease in idiopathic pulmonary fibrosis: viewer or actor? to treat or not to treat?[J]. Pharmaceuticals, 2022, 15(8): 1033. doi:10.3390/ph15081033
[36] Su YL, Shen L, Zhang F, et al. Laryngopharyngeal pH monitoring in patients with idiopathic pulmonary fibrosis[J]. Front Pharmacol, 2021, 12: 724286. doi:10.3389/fphar.2021.724286
[37] Yang M, Dong JJ, An J, et al. Effect of anti-reflux therapy on pulmonary function in idiopathic pulmonary fibrosis: a systematic review and meta-analysis[J]. J Thorac Dis, 2021, 13(10): 5776-5787. doi:10.21037/jtd-21-771
[1] 乐冰艳,邹剑,雷蕾,文巧,钱应雪. 儿童扁桃体微生物群与免疫调节及疾病关联[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 193-200.
[2] 周荷青,申琪. 中医药治疗变应性鼻炎疗效的生物标志物研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 168-176.
[3] 吴玮,王磊,陈升,李连勇,王刚. 胃食管气道反流性疾病多学科研究及进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 1-14.
[4] 刘莲莲,李进让. 阻塞性睡眠呼吸暂停与咽喉反流[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 15-22.
[5] 胡志伟,陈冬,杨栋,吴继敏. 胃食管气道反流性疾病的诊断和治疗:基于2020~2024年相关共识和指南[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 30-38.
[6] 赵佳宁,崔元馨,王丹,赵明. 咽喉反流与复发性呼吸道乳头状瘤病的关系及其机制探讨[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 39-45.
[7] 张杉,陈秋,周方伟,马亦飞. 生物标志物在咽喉反流性疾病中的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 46-54.
[8] 周诗侗,杨艳艳,杨玉成,方红雁. 胃蛋白酶与咽喉反流性疾病:从致病机制到咽喉鳞状细胞癌的潜在风险因素[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 55-60.
[9] 席晓宇,隋昕珂,陈升,李连勇,钟长青. 咽喉反流性疾病的内镜下治疗[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 61-65.
[10] 牛燕燕,顾伟,金晓峰,霍红,杨大海,崔婷婷,王剑. 声带白斑组织中胃蛋白酶的表达分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 66-70.
[11] 王磊,王刚,孙喆喆,刘红丹,韩浩伦,李保卫,张晓丽,吴玮. 咽喉反流与声带良性增生性病变、声带白斑、慢性咽喉炎相关性研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 71-77.
[12] 崔小缓,尹龙龙,张延平,蒋兴旺,李丽娜. 咽喉反流患者唾液菌群与反流症状相关性分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 78-84.
[13] 李逗,隋昕珂,杨小慢,郭红媛,王敏,钟长青,李连勇. 单纯咽喉反流患者食管下段黏膜细胞内镜及病理指标变化[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 85-90.
[14] 孙喆喆,王刚,王磊,李保卫,韩浩伦,刘红丹,张晓丽,吴玮. 咽喉反流性疾病不同体位反流模式的研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 91-95.
[15] 魏鑫,邢东升,翟振伟,阎艾慧,刘振宇,曹弘薇. 妊娠期女性咽喉反流症状指数调查及影响因素分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(6): 96-102.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!